title: Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
abstract: Adalimumab is a frequently prescribed TNFalpha inhibitor for treatment of rheumatoid arthritis. We report on a patient who probably developed a Miller-Fisher syndrome after the second injection of adalimumab.
authors.affiliation: Department of Rheumatology, Hôpital Neuchâtelois, CH-2300, La Chaux-de-Fonds, Switzerland.
authors.forename: Patric Thierry
authors.initials: PT
authors.lastname: Kurmann
authors.forename: Daniel
authors.initials: D
authors.lastname: Van Linthoudt
authors.forename: Alexander Kai-Lik
authors.initials: AK
authors.lastname: So
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000588:Amines / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D000077206:Gabapentin; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D019846:Miller Fisher Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D003509:Cyclohexanecarboxylic Acids; D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000068879:Adalimumab; D001379:Azathioprine